New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Morrow accepts the following list of insurance providers. Select your insurance provider to see more details.
Memorial Sloan Kettering is an in-network provider with Aetna HMO, POS, and PPO plans. Aetna does not include us in any of the plans you can purchase through the insurance exchanges or through Medicare. Please ask your insurance if you need a one-time referral. MSK has an agreement with the Aetna Transplant Program for all Aetna's commercial products.
Memorial Sloan Kettering is a designated Blue Distinction Center for bone marrow transplant and CAR-T.
We understand that there may be many complexities involved with insurance coverage purchased through the health exchange network of the Affordable Care Act. We’re here to help. If you have questions about how your care will be covered by an insurance provider, or need help navigating a change in coverage, please call us at 646-227-3378; if you are not a resident of New York, you can call us at 866-248-1274. Our team is here to listen to your concerns and assist you in any way we can. We want our care to be as accessible and affordable for as many people as possible.
Memorial Sloan Kettering is an in-network provider with CIGNA's HMO, POS, and PPO plans. CIGNA does not include us in any of the plans you can buy through the insurance exchanges.
- If you are a New York State resident: Please ask your insurance if you need a one-time referral.
- If you live outside of New York State: Please ask your insurance if you have in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with EmblemHealth’s PPO, EPO, POS, HMO plans. EmblemHealth includes GHI, HIP, Vytra, and ConnecticCare (in NYS Only). You must bring a referral from your Emblem primary care doctor to your first appointment. In-network participation exceptions include:
- Emblem’s HIP Commercial Millennium, Select Care and Enhanced Care Prime networks is not in-network with Memorial Sloan Kettering.
- Please call Emblem to confirm if your specific plan is in-network.
For information regarding Memorial Sloan Kettering’s participation with Emblem’s Medicare Advantage Plans, please refer to the Medicare & Medicaid page
Memorial Sloan Kettering is an in-network provider with Empire Blue Cross Blue Shield (Wellpoint) of New York Indemnity, HMO, EPO, PPO, POS and Medicare Advantage plans, with the following exceptions:
- Empire Blue Cross Blue Shield does not include us in any of the plans you can buy through the insurance exchanges.
- Please call Empire BCBS to confirm if your specific plan is in-network with Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with HealthFirst’s commercial products; these commercial products are not purchased on the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with HealthSmart’s Accel, HSPC, and HPO networks.
For our NJ locations, Memorial Sloan Kettering is an in-network provider with most Horizon Blue Cross Blue Shield of New Jersey plans for individuals, families, and small businesses. Horizon members with Blue Card Access (there would be a suitcase logo on the front of the card) may have access to our NY locations. Please call Horizon to confirm if your plan is in-network in NY.
Memorial Sloan Kettering is a designated Center of Excellence by Humana.
Memorial Sloan Kettering is a designated Center of Excellence by Interlink Health Services.
Memorial Sloan Kettering is a designated Center of Excellence by Lifetrac.
Memorial Sloan Kettering is an in-network provider for all MagnaCare health plans except those products you can buy through the insurance exchanges.
For information about Medicare and Medicaid, please visit this page
Memorial Sloan Kettering is an in-network provider with some Multiplan/Beech Street/PHCS plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is a designated Center of Excellence by Multiplan.
If you are covered by more than one insurance plan, you will want to determine your benefits from both plans. First, you need to determine which one is your primary insurance provider by contacting your employee benefits office or your insurance carriers. After you find out which is your primary insurance provider, you should then contact your insurance carrier to determine if you have access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with some MVP plans. Contact your insurance carrier to find out if your plan provides in-network access to Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider for New York State employees who have enrolled in UnitedHealthcare's Cancer Resource Services. If you have the Empire Plan, you should call Cancer Resources Services at 866-936-6002 to verify and enroll in this coverage.
Memorial Sloan Kettering is in-network with Oscar’s Circle Plus Network, a part of its Small Group Broad line that is offered only to select small business groups. Oscar does not include Memorial Sloan Kettering as an in-network provider for any of its individual plans. Please confirm eligibility with your insurance carrier.
Most Blue Cross Blue Shield plans include Memorial Sloan Kettering as an in-network provider. Contact your insurance company to confirm if Memorial Sloan Kettering is in-network.
We have agreements with several insurance companies that may provide additional coverage for cancer patients. These benefit programs include:
- AXA Assistance USA
- Beech Street
- Integrated Health Plans
- National Health Administrators
- National Preferred Provider Network
- UnitedHealthcare's Cancer Resource Services
- United Resource Network
- Veterans Choice Program
Memorial Sloan Kettering is an in-network provider with Oxford’s Freedom and Liberty plans as well as the Metro Plan (which is only offered to small business groups and no longer offered as individual plans). Please confirm with your insurance if you need a one-time referral. Note: Oxford’s Medicare Managed Care plan — Secure Horizon — does not include Memorial Sloan Kettering as an in-network provider. Oxford does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is an in-network provider with the World Trade Center Health Program.
Memorial Sloan Kettering is an in-network provider with QualCare's PPO and HMO/POS network.
Memorial Sloan Kettering is a designated Center of Excellence by Specialty Care Management.
Hospital and physician services may be covered by TRICARE. Please call your TRICARE plan to confirm coverage at Memorial Sloan Kettering.
Memorial Sloan Kettering is an in-network provider with UnitedHealthCare's HMO, POS, and PPO plans. Please confirm with your insurance if a one-time referral is needed.
UnitedHealthCare's Medicare Managed Care plan does not include Memorial Sloan Kettering as an in-network provider.
United does not include us in any of the plans you can buy through the insurance exchanges.
Memorial Sloan Kettering is a designated Center of Excellence by UnitedHealthcare.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Jefferson Medical College
General Surgery - Medical Center Hospital of Vermont
General Surgical Oncology - Memorial Sloan Ketttering Cancer Center
I am a surgical oncologist with a practice dedicated to the care of people with breast cancer. I treat all types of the disease and most stages, except for metastatic breast cancer that has spread beyond the breast and lymph nodes. My goal is to make sure that my patients and their loved ones understand their treatment options by taking the time to answer all their questions. I help them make informed decisions that will lead to the best possible outcomes. It’s important that they feel confident about their treatment plan and the devoted team of specialists at Memorial Sloan Kettering Cancer Center who will take care of them.
When patients first come to see me, they are often scared because they have been told they have a potentially life-threatening disease, or perhaps because they are afraid of being disfigured. Many newly diagnosed patients are also confused because there is so much information out there about breast cancer, some of which is incorrect, that it is hard for them to figure out what applies to them and what does not.
I truly believe that knowledge is power, and it’s important to distinguish between what is scientific fact and what may be someone else’s personal experience. My goal is to provide people with the information they need to understand their disease and face the challenge of treatment. We also cannot know every treatment a person will need based only on a biopsy that shows breast cancer, so I explain that the treatment process unfolds step-by-step. I try to allay the sense of panic that often comes with diagnosis to allow people to be more comfortable as their treatment journey unfolds.
The way we treat breast cancer began to change dramatically during my training to become a surgical oncologist. It’s been wonderful to be able to offer patients improved, less radical surgical approaches. Breast cancer is a common disease that affects people of all ages and races and ethnicities. It runs the spectrum, from very aggressive to very slow-growing. Understanding how best to treat each individual and their cancer is a challenge that has kept me dedicated to clinical care and research throughout my career.
My research has focused on how to apply advances from clinical trials to daily surgical practice. I am currently investigating how treatment choices for breast cancer surgery are made — such as how well patients understand their options and when it is more beneficial for a person newly diagnosed with breast cancer to have chemotherapy before surgery to reduce the extent of the operation.
I have co-chaired two joint committees of the American College of Surgeons, American College of Radiology, and College of American Pathologists: Standards for Breast Conserving Therapy for Invasive Breast Cancer (2002), and Standards for Breast Conserving Therapy in Ductal Carcinoma In Situ (DCIS) (2007). I also co-chaired committees for the Society of Surgical Oncology (SSO) and American Society for Therapeutic Radiation Oncology (ASTRO) to develop standards for margins for lumpectomy in invasive breast cancer (2013) and DCIS (2015), and I have served as an Associate Editor of JAMA Oncology since 2014.
I am the surgical editor of the textbook Diseases of the Breast and a co-author of Breast Cancer for Dummies. I was the 2012–13 President of the Society of Surgical Oncology, the professional organization for surgeons who specialize in cancer treatment.
Awards and Honors
- Charles M. Balch Distinguished Service Award, Society of Surgical Oncology (2022)
- Castle Connolly: New York Magazine Top Doctors (2008-2021)
- John Wayne Clinical Research Award, Society of Surgical Oncology (2019)
- St. Gallen International Breast Cancer Award (2019)
- Impact Award, Breast Cancer Society of Taiwan (2016)
- Susan G. Komen Brinker Award for Scientific Distinction in Clinical Research (2016)
- Lifetime Achievement Award, Vienna Breast Surgery Conference, University of Vienna (2015)
- Honorary Fellow, Royal College of Surgeons of Ireland (2012)
- Honorary Fellow, Royal College of Physicians and Surgeons Glasgow (2005)
- Clinical Trials Investigated by Dr. Morrow
- A Phase III Study Evaluating of the Role of Axillary (Armpit) Lymph Node Removal in Patients with Breast Cancer with Positive Sentinel Lymph Nodes after Preoperative Chemotherapy
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Selected Books and Book Chapters
“Uncommon presentations of cancer affecting the breast.” Miller ME, Morrow M. In: A Companion to Specialist Surgical Practice Breast Surgery 6e. Dixon, JM, Barber MD, eds. Elsevier. 2019
“Surgical margins in breast-conserving surgery.” Mantani A, Corben AD, Morrow M. In: Oncoplastic and Reconstructive Breast Surgery, 2nd Edition. Urban C. Rietjens M, El-Tamer M, Sacchini VS, eds. Springer. New York, 2016.
“Mastectomy.” Morrow M, Golshan M..Chapter 34: In: Diseases of the Breast. 5th ed. Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Philadelphia: Lippincott Williams & Wilkins. 2014.
“Breast-conserving therapy.” Chapter 36: Morrow M, Harris JR. In: Diseases of the Breast. 5th ed. Harris JR, Lippman ME, Morrow M, Osborne K, eds. Philadelphia: Lippincott Williams & Wilkins. Philadelphia. 2014.
“Malignant tumors of the breast.” Burstein MJ, Harris JR, Morrow M. In: Cancer: Principles and Practice of Oncology. 9th ed. Devita V, Lawrence T, Rosenberg S, eds. Philadelphia: Lippincott Williams & Wilkins; 2011: 1392-1400.
“Breast cancer in the elderly.” Wiechmann L, Morrow M. In: Principles and Practice in Geriatric Surgery. 2nd ed. Rosenthal RA, Zenilman ME, Katlic MR, eds. NewYork: Springer; 2011: 479-92.
“DCIS and microinvasive carcinoma.” Morrow M, Harris JR. In: Diseases of the Breast. 4th ed. Harris, Lippman, Morrow, Osborne, eds. Philadelphia: Lippincott Williams & Wilkins; 2010: 349-62.
Visit PubMed for a full listing of Dr. Morrow’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Monica Morrow discloses the following relationships and financial interests:
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.